# Safety of Intravenous Neridronic Acid in CRPS

> **NCT02972359** · PHASE3 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 580 (actual)

## Conditions studied

- Complex Regional Pain Syndrome

## Interventions

- **DRUG:** Neridronic acid

## Key facts

- **NCT ID:** NCT02972359
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-20
- **Primary completion:** 2019-01-09
- **Final completion:** 2019-01-09
- **Target enrollment:** 580 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972359, "Safety of Intravenous Neridronic Acid in CRPS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02972359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*